This differs from rarer situations of pronouncedly excessive insulin secretion, as with insulinomas (i.e., insulin-producing pancreatic tumors), which are the most common endogenous causes of hypoglycemia (largely due to decreased hepatic glucose output rather than increased insulin-stimulated glucose utilization; Grant 2005). The gene discussed is INS; the disease is pancreatic insulinoma.